CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...
Phase 1, Phase 2
Indianapolis, Indiana, United States of America and 14 other locations
participants with relapsed or refractory (R/R) diffuse-large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, transformed folli...
Phase 3
Noblesville, Indiana, United States and 62 other locations
Phase 1, open-label, multicenter study of WTX-330 administered as a monotherapy to patients with advanced or metastatic solid tumors or non- ...
Phase 1
Indianapolis, Indiana, United States and 8 other locations
The purpose of this single-arm, open-label, Phase 1b/2a, multicenter basket study is to evaluate whether tafasitamab and parsaclisib can be safely co...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 49 other locations
in participants with relapsed or refractory (R/R) solid tumors or non-Hodgkin lymphoma (NHL).Part 2: Cohort Expansion. The...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 24 other locations
B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this stud...
Phase 1
Indianapolis, Indiana, United States and 26 other locations
20-expressing Non-Hodgkin lymphoma....
Phase 1
Indianapolis, Indiana, United States and 6 other locations
is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....
Phase 3
Noblesville, Indiana, United States and 113 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...
Phase 2
Indianapolis, Indiana, United States and 61 other locations
is focused on participants with previously untreated follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin...
Phase 3
Noblesville, Indiana, United States and 64 other locations
Clinical trials
Research sites
Resources
Legal